Pura Vida Investments, LLC In its 13F for Q2 2024 (holdings as of June 30, 2024, filed August 14, 2024), Pura Vida Investments, LLC reported 25 stock positions worth $82.7 million . Its top holding was Establishment Labs (ESTA) at 12.6% of the portfolio, followed by Glaukos (GKOS, 12.5% ) and Intuitive Surgical (ISRG, 10.2% ). Compared with Q1 2024, it opened 9 new positions, sold out of 14, added to 5 and reduced 10. The biggest buy was Glaukos (GKOS, shares +10% ) and the biggest sale an exit from Exact Sciences (EXAS).
Location NEW YORK, NY
CIK 0001590144
Portfolio Value $82.7M (Q2 2024) Holdings 25 stocks · $82.7M Holdings quarter Q2 2026 Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024
Stock % Of Portfolio ▼ Shares Held Total Value Change vs Q1 2024 ESTA Establishment Labs Holdings 230,093 $10.5M Reduce -12.1% GKOS Glaukos Corp. 87,000 $10.3M Add +10.1% ISRG Intuitive Surgical Inc. 18,900 $8.4M Reduce -21.4% NTRA Natera Inc. 67,500 $7.3M Reduce -5.7% MSOS Advisorshares Pure US Cann 787,000 $5.8M Add +35.7% QTRX Quanterix Corp. 409,334 $5.4M Add +8.9% LIVN Livanova PLC 78,350 $4.3M Reduce -13.1% ICUI Icu Medical Inc. 29,334 $3.5M New CSTL Castle Biosciences Inc. 153,386 $3.3M New LUNG Pulmonx Corp. 512,964 $3.3M Add +9.9% MASI Masimo Corp. 25,000 $3.1M New ATEC Alphatec Holdings Inc. 199,000 $2.1M Reduce -37.8% BRKR Bruker Corp. 32,500 $2.1M New CUTRQ Cutera Inc. 1,165,799 $1.8M Add +8.1% TNDM Tandem Diabetes Care Inc. 40,500 $1.6M Reduce -4.7% BVS Bioventus Inc. Class A 280,000 $1.6M New IMDX Insight Molecular Diagnostic filed as ONCOCYTE CORP 495,345 $1.5M Reduce -5.5% STAA Staar Surgical Co. 30,000 $1.4M New ZIMV Zimvie Inc. 70,000 $1.3M Reduce -4.2% NSPR Inspiremd Inc. 450,517 $1.1M No change MGX Metagenomi Therapeutics Inc. 270,618 $1.0M Reduce -41.3% ELAN Elanco Animal Health Inc. 56,603 $817K Reduce -70.7% TWST Twist Bioscience Corp. 10,000 $493K New NARI Inari Medical Inc. 10,000 $482K New WGS Genedx Holdings Corp. 10,000 $261K New
Options reported separately and not counted above: SPY puts ($13.6M), QQQ puts ($9.6M), MASI calls ($5.6M), ACWX puts ($5.0M), XITK puts ($4.6M), RMD puts ($4.6M), IXP puts ($4.1M), INSP puts ($4.0M), GH calls ($2.9M), ARKG puts ($2.7M), COO calls ($2.6M), LIVN calls ($2.6M), and 10 more.
Other holdings (2): bonds, preferreds, convertibles and warrants · $26K (not counted above) Security Class Shares / Principal Value Change TALKW Hudson Executive Inv -CW25 *W EXP 06/21/202 238,500 $24K Reduce -36.9% MAPSW WM Technology Inc.-CW24 *W EXP 06/16/202 50,000 $3K No change
Total filed on the 13F, all lines: $82.7M.
Portfolio Sells Q1 2024 → Q2 2024 Portfolio Sells quarter Q2 2026 Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024
Stock Change vs Q1 2024 % Of Portfolio Change To Portfolio ▲ EXAS Exact Sciences Corp. Sold out 0.00% −22.66 LYRA Lyra Therapeutics Inc. Sold out 0.00% −5.99 DXCM Dexcom Inc. Sold out 0.00% −2.83 VKTX Viking Therapeutics Inc. Sold out 0.00% −2.23 INSP Inspire Medical Systems Inc. Sold out 0.00% −2.19 MGX Metagenomi Therapeutics Inc. Reduce -41.3% 1.26% −2.06 SWAV Shockwave Medical Inc. Sold out 0.00% −1.94 RGEN Repligen Corp. Sold out 0.00% −1.41 GH Guardant Health Inc. Sold out 0.00% −1.40 ELAN Elanco Animal Health Inc. Reduce -70.7% 0.99% −1.15 EW Edwards Lifesciences Corp. Sold out 0.00% −1.00 TXG 10X Genomics Inc. Class A Sold out 0.00% −0.97 BAX Baxter International Inc. Sold out 0.00% −0.87 TMCI Treace Medical Concepts Inc. Sold out 0.00% −0.80 MYGN Myriad Genetics Inc. Sold out 0.00% −0.65 ATEC Alphatec Holdings Inc. Reduce -37.8% 2.51% −0.49 RCEL Avita Medical Inc. Sold out 0.00% −0.38 IMDX Insight Molecular Diagnostic Reduce -5.5% 1.77% +0.72 ZIMV Zimvie Inc. Reduce -4.2% 1.54% +0.72 TNDM Tandem Diabetes Care Inc. Reduce -4.7% 1.97% +0.95 LIVN Livanova PLC Reduce -13.1% 5.19% +1.76 ESTA Establishment Labs Holdings Reduce -12.1% 12.64% +3.57 ISRG Intuitive Surgical Inc. Reduce -21.4% 10.17% +3.63 NTRA Natera Inc. Reduce -5.7% 8.84% +4.38
Portfolio Buys Q1 2024 → Q2 2024 Portfolio Buys quarter Q2 2026 Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024
Stock Change vs Q1 2024 % Of Portfolio Change To Portfolio ▼ GKOS Glaukos Corp. Add +10.1% 12.45% +7.38 ICUI Icu Medical Inc. New 4.21% +4.21 CSTL Castle Biosciences Inc. New 4.04% +4.04 MASI Masimo Corp. New 3.81% +3.81 MSOS Advisorshares Pure US Cann Add +35.7% 6.98% +3.02 BRKR Bruker Corp. New 2.51% +2.51 BVS Bioventus Inc. Class A New 1.95% +1.95 STAA Staar Surgical Co. New 1.73% +1.73 CUTRQ Cutera Inc. Add +8.1% 2.13% +1.05 LUNG Pulmonx Corp. Add +9.9% 3.93% +0.99 TWST Twist Bioscience Corp. New 0.60% +0.60 NARI Inari Medical Inc. New 0.58% +0.58 QTRX Quanterix Corp. Add +8.9% 6.54% +0.51 WGS Genedx Holdings Corp. New 0.32% +0.32
Options Activity Q1 2024 → Q2 2024 Security Type Change vs Q1 2024 Underlying Shares Value ▼ ISHARES TR put Sold out 705,000 $148.3Mbefore exit HUMANA INC call Sold out 175,000 $60.7Mbefore exit STATE STR SPDR S&P 500 ETF T put Sold out 80,000 $41.8Mbefore exit ISHARES TR put Sold out 659,000 $38.6Mbefore exit EXACT SCIENCES CORP call Sold out 495,100 $34.2Mbefore exit SPDR SERIES TRUST put Sold out 340,000 $32.3Mbefore exit INVESCO QQQ TR put Sold out 60,000 $26.6Mbefore exit SPY SS SPDR S&P 500 ETF Trust-US put New 25,000 $13.6M ARK ETF TR put Sold out 400,000 $11.5Mbefore exit QQQ Invesco QQQ Trust Series 1 put New 20,000 $9.6M ADVISORSHARES TR call Sold out 950,000 $9.5Mbefore exit LIVANOVA PLC call Sold out 145,400 $8.1Mbefore exit ARK ETF TR put Sold out 150,000 $7.5Mbefore exit GUARDANT HEALTH INC call Sold out 323,300 $6.7Mbefore exit MASI Masimo Corp. call New 44,500 $5.6M RESMED INC put Sold out 28,000 $5.5Mbefore exit ACWX iShares MSCI Acwi Ex US ETF put New 90,000 $5.0M XITK SS SPDR F Inno Tech ETF put New 50,000 $4.6M RMD Resmed Inc. put New 24,000 $4.6M BAUSCH HEALTH COS INC call Sold out 400,000 $4.2Mbefore exit IXP iShares Global Comm Services put New 20,000 $4.1M INSP Inspire Medical Systems Inc. put New 30,000 $4.0M INSPIRE MED SYS INC put Sold out 17,500 $3.8Mbefore exit INSPIRE MED SYS INC call Sold out 15,000 $3.2Mbefore exit GH Guardant Health Inc. call New 100,000 $2.9M ARKG ARK Genomic Revolution ETF put New 115,000 $2.7M COO The Cooper Cos Inc. call New 30,000 $2.6M LIVN Livanova PLC call New 46,700 $2.6M INTUITIVE SURGICAL INC call Sold out 6,000 $2.4Mbefore exit MDT Medtronic PLC put New 30,000 $2.4M ARKK ARK Innovation ETF put New 50,000 $2.2M DHR Danaher Corp. put New 7,500 $1.9M STAA Staar Surgical Co. call New 30,000 $1.4M INMODE LTD put Sold out 61,600 $1.3Mbefore exit SOLV Solventum Corp. put New 21,000 $1.1M STE Steris PLC put New 5,000 $1.1M INMD Inmode Ltd. put New 60,000 $1.1M PEN Penumbra Inc. put New 6,000 $1.1M GEHC GE Healthcare Technology put New 10,000 $779K ENOV Enovis Corp. put New 8,000 $362K
Calls and puts are listed by the shares they cover; their value is not part of the stock holdings above.
Notes & Other Activity Q1 2024 → Q2 2024 Security Class Change vs Q1 2024 Shares / Principal Value ▼ TALKW Hudson Executive Inv -CW25 *W EXP 06/21/202 Reduce -36.9% 238,500 $24K RCKTW Rocket Pharmaceuticals in-27 *W EXP 09/02/202 Sold out 42,960 $13Kbefore exit
Bonds, preferreds, convertibles and warrants; not part of the stock holdings or percentages above.
All Filings Quarter Positions 13F Reported Value Top Holdings Q2 2026 19 $37.0M ALMR, BBNX, ESTA, IMDX, NVDA Q1 2026 17 $14.9M IMDX, BBNX, ESTA, CAI, NSPR Q4 2025 18 $26.8M BBNX, IMDX, ESTA, CAI, NSPR Q3 2025 8 $16.4M BBNX, IMDX, CAI, ESTA, NSPR Q2 2025 8 $16.6M BBNX, IMDX, CAI, ESTA, OM Q1 2025 8 $13.7M BBNX, IMDX, ESTA, NSPR, KMTS Q4 2024 9 $18.1M ESTA, MSOS, LUNG, QTRX, IMDX Q3 2024 16 $60.8M MSOS, ESTA, GKOS, NTRA, ISRG Q2 2024 25 $82.7M ESTA, GKOS, ISRG, NTRA, MSOS Q1 2024 30 $146.8M EXAS, ESTA, ISRG, QTRX, LYRA